A Trial Comparing the Efficacy and Safety of Adding Liraglutide Versus Addition of Insulin Aspart With the Largest Meal to Insulin Degludec, Both in Combination With Metformin, in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification (BEGIN: VICTOZA ADD-ON)
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Insulin degludec (Primary) ; Insulin aspart; Liraglutide; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms BEGIN; BEGIN-VICTOZA-ADD-ON
- 22 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 22 Jun 2013 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met.
- 12 Mar 2013 New trial record